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Enterotoxigenic Escherichia coli (ETEC) that bear F4 fimbriae on their 
surface (F4+ ETEC) are a major cause of postweaning diarrhoea (PWD) in pigs. The 
F4 fimbriae enable the bacteria to colonize the small intestine and subsequently, to 
produce enterotoxins causing diarrhoea. Consequently, an F4-specific secretory IgA 
response at the intestinal mucosa that neutralizes the fimbriae is desired for protection 
against postweaning diarrhoea.   
Several strategies were tested in our lab to activate the intestinal mucosal 
immune system. In a first trial, we demonstrated that oral immunization of weaned 
F4-receptor positive (F4R+) pigs with soluble F4 fimbriae results in an antigen-
specific secretory IgA response at the intestinal mucosa, preventing colonization of 
the bacteria and consequently, protecting the pigs against infection. However, to 
protect newly weaned pigs, the immune system should already be primed during the 
suckling period. During this period, the F4 fimbriae might be partially inactivated by 
maternal antibodies and other milk-factors. In order to overcome this, enteric-coated 
pellets containing the F4 fimbriae were developed. The pellets function by shielding 
the F4 during transport through the stomach and the duodenum and releasing the 
fimbriae at the beginning of the jejunum, close to the major intestinal immune 
induction sites, namely the jejunal Peyers patches. Oral vaccination of suckling pigs 
with these enteric-coated pellets resulted in a marginal but significant reduction in 
faecal F4+ ETEC excretion upon challenge infection. Nevertheless, in contrast to 
soluble F4 administration to weaned pigs, this could not prevent colonisation of the 
small intestine with F4+ ETEC.  Subsequently, the F4 fimbriae were encapsulated in 
Gantrez nanoparticles. These nanoparticles were not expected to release the F4 in the 
jejunum, but only after transport through the intestinal epithelium. As compared to 
soluble F4, encapsulation of F4 in Gantrez nanoparticles didn’t improve protection 
against F4+ ETEC, but did improve the serum IgG and IgA response in an oral 
immunisation experiment of weaned pigs. However, when suckling pigs were 
vaccinated, a positive effect of the Gantrez nanoparticles on the serum antibody 
response could neither be observed. 
A second strategy we tested in order to activate the intestinal mucosal immune 
system was systemic vaccination using immunomodulating adjuvants. As succesfull 
results were already obtained in mice using 1α,25(OH)2D3, the active form of 
vitamine D3, this adjuvant was tested in an intramuscular immunization experiment in 
pigs using the model antigen human serum albumin (HSA). Coadministration of 
1α,25(OH)2D3 to HSA enhanced the serum IgA and IgM response and the IgA 
response in faeces, saliva and nasal secretions. In addition, it sligthly increased the 
number of HSA-specific IgA antibody-secreting cells (ASC), suggesting that priming 
of the intestinal mucosal immune system occured. To test this, pigs were immunized 
intramuscularly with soluble F4 in presence or absence of 1α,25(OH)2D3 and 
protection against F4+ ETEC was evaluated. In the 1α,25(OH)2D3 group, a secretory 
IgA response after infection and a reduced excretion of F4+ ETEC in faeces could be 
observed. Nevertheless, the duration of faecal F4+ ETEC excretion was not reduced, 
indicating that colonization could not be prevented. Currently, we are analyzing the 
immunomodulating effect of retinoic acid, the metabolite of vitamin A on 
intramuscular immunization of pigs with HSA. Retinoic acid is produced by dendritic 
cells in the small intestinal lamina propria, Peyers’ patches and mesenteric lymph 
nodes and is suggested to be involved in the imprinting of gut-homing specificity on 
lymphocytes. The results of this experiment are under evaluation. 
